Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $5.2 Billion Buyout – Investor's Business Daily

Business News

  1. Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $5.2 Billion Buyout  Investor’s Business Daily
  2. Novo Nordisk to Acquire Akero Therapeutics for Up to $5.2 Billion  The Wall Street Journal
  3. Novo Nordisk Is Buying Akero Therapeutics. It’s More Good News for Biotech Stocks.  Barron’s
  4. Novo Nordisk to buy Akero Therapeutics, picking up promising MASH drug  statnews.com
  5. Novo CEO Says Risk-Taking, Deals Are Needed to Win Obesity Race  Bloomberg.com

Source: Business News

/by